Audax-owned Laborie invests in Israel's Medi-Tate
Laborie Medical Technologies Inc, a portfolio company of U.S. private equity firm Audax Group, has made a strategic investment in Medi-Tate Ltd, an Akiva, Israel-based medical device company. No financial terms were disclosed. Founded in 2007, Medi-Tate is the developer of iTind, a procedure to treat the symptoms of enlarged prostate in men. Medi-Tate said the partnership with Laborie will help it to deliver the solution to over 500 million patients. Laborie, a Toronto-based provider of urodynamic testing equipment and consumables, was bought by Audax in July 2012.
7 July 2016•2 mins read
